Back to Mariner, LLC Mariner, LLC

AXSM

15 quarters

Position history for Mariner, LLCMariner, LLC's holdings in Axsome Therapeutics, Inc.

Yes. Mariner holds 18,262 shares of AXSM (Axsome Therapeutics), worth $4.5M, as of its Q2 2026 13F filing. It increased the position by 1,448 shares (+8.6%) from Q1 2026. Mariner has held AXSM since Q4 2023, across 11 quarterly 13F filings.

Current Value

$4.5M

Current Shares

18,262

Total Value Change

+$4.4M

Total Shares Change

-23,263

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
18,262
+8.6%
$4.5M0.0%$244.77
29
2026-Q1
Increased
16,814
+10.0%
$2.8M0.0%$169.02
29
2025-Q4
Decreased
15,288
-8.0%
$2.8M0.0%$182.64
0
2025-Q3
Increased
16,617
+6.6%
$2M0.0%$121.45
28
2025-Q2
Increased
15,594
+5.6%
$1.6M0.0%$104.39
27
2025-Q1
Decreased
14,771
-2.3%
$1.7M0.0%$116.63
0
2024-Q4
Increased
15,120
+13.8%
$1.3M0.0%$84.61
29
2024-Q3
Increased
13,286
+323.5%
$1.2M0.0%$89.87
41
2024-Q2
Increased
3,137
+20.0%
$252,5290.0%$80.50
28
2024-Q1
Decreased
2,614
-4.2%
$208,5970.0%$79.80
0
2023-Q4
New
2,729
-
$217,2010.0%$79.59
32
2019-Q3
Exited
0
-100.0%
$00.0%$20.24
0
2019-Q2
Increased
23,025
+7.0%
$593,0000.0%$25.75
26
2019-Q1
Decreased
21,525
-48.2%
$306,0000.0%$14.23
0
2018-Q4
First report
41,525
-
$117,0000.0%$2.82
0

Other major holders of AXSM: Vanguard Group Inc., BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used